Osteobiologic agents in spine surgery

Vivek Mohan, Munish C. Gupta

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The treatment of spinal disorders has evolved greatly over the last 30. years, with developments in instrumentation and biologics. Pedicle screw technology has improved fusion rates. However, even with these advances the dilemma of non-unions in spinal surgery still exists. Patients with challenging deformities or biology continue to have high rates of non-unions and autograft harvest carries its own set of complications. With the current plethora of biologics available for use, every spine surgeon should understand bone biology and the utility of each product for the benefit of their patients. In this chapter, we will discuss the biology of spinal fusions and detail each major category of biological products, from autograft to ceramics, while detailing their indications and known complications.

Original languageEnglish (US)
Title of host publicationBiomaterials for Spinal Surgery
PublisherElsevier Ltd
Pages233-261
Number of pages29
ISBN (Print)9781845699864
DOIs
StatePublished - Mar 2012

Fingerprint

Biological Products
Surgery
Autografts
Fusion reactions
Bone

Keywords

  • Allograft
  • Autograft
  • Bone formation
  • Bone morphogenic protein
  • Cellular concentrates
  • Ceramics
  • Spinal fusion
  • Stem cells

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Mohan, V., & Gupta, M. C. (2012). Osteobiologic agents in spine surgery. In Biomaterials for Spinal Surgery (pp. 233-261). Elsevier Ltd. https://doi.org/10.1016/B978-1-84569-986-4.50006-4

Osteobiologic agents in spine surgery. / Mohan, Vivek; Gupta, Munish C.

Biomaterials for Spinal Surgery. Elsevier Ltd, 2012. p. 233-261.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mohan, V & Gupta, MC 2012, Osteobiologic agents in spine surgery. in Biomaterials for Spinal Surgery. Elsevier Ltd, pp. 233-261. https://doi.org/10.1016/B978-1-84569-986-4.50006-4
Mohan V, Gupta MC. Osteobiologic agents in spine surgery. In Biomaterials for Spinal Surgery. Elsevier Ltd. 2012. p. 233-261 https://doi.org/10.1016/B978-1-84569-986-4.50006-4
Mohan, Vivek ; Gupta, Munish C. / Osteobiologic agents in spine surgery. Biomaterials for Spinal Surgery. Elsevier Ltd, 2012. pp. 233-261
@inbook{ae062bfac67646cd9e7a6793eee98653,
title = "Osteobiologic agents in spine surgery",
abstract = "The treatment of spinal disorders has evolved greatly over the last 30. years, with developments in instrumentation and biologics. Pedicle screw technology has improved fusion rates. However, even with these advances the dilemma of non-unions in spinal surgery still exists. Patients with challenging deformities or biology continue to have high rates of non-unions and autograft harvest carries its own set of complications. With the current plethora of biologics available for use, every spine surgeon should understand bone biology and the utility of each product for the benefit of their patients. In this chapter, we will discuss the biology of spinal fusions and detail each major category of biological products, from autograft to ceramics, while detailing their indications and known complications.",
keywords = "Allograft, Autograft, Bone formation, Bone morphogenic protein, Cellular concentrates, Ceramics, Spinal fusion, Stem cells",
author = "Vivek Mohan and Gupta, {Munish C.}",
year = "2012",
month = "3",
doi = "10.1016/B978-1-84569-986-4.50006-4",
language = "English (US)",
isbn = "9781845699864",
pages = "233--261",
booktitle = "Biomaterials for Spinal Surgery",
publisher = "Elsevier Ltd",

}

TY - CHAP

T1 - Osteobiologic agents in spine surgery

AU - Mohan, Vivek

AU - Gupta, Munish C.

PY - 2012/3

Y1 - 2012/3

N2 - The treatment of spinal disorders has evolved greatly over the last 30. years, with developments in instrumentation and biologics. Pedicle screw technology has improved fusion rates. However, even with these advances the dilemma of non-unions in spinal surgery still exists. Patients with challenging deformities or biology continue to have high rates of non-unions and autograft harvest carries its own set of complications. With the current plethora of biologics available for use, every spine surgeon should understand bone biology and the utility of each product for the benefit of their patients. In this chapter, we will discuss the biology of spinal fusions and detail each major category of biological products, from autograft to ceramics, while detailing their indications and known complications.

AB - The treatment of spinal disorders has evolved greatly over the last 30. years, with developments in instrumentation and biologics. Pedicle screw technology has improved fusion rates. However, even with these advances the dilemma of non-unions in spinal surgery still exists. Patients with challenging deformities or biology continue to have high rates of non-unions and autograft harvest carries its own set of complications. With the current plethora of biologics available for use, every spine surgeon should understand bone biology and the utility of each product for the benefit of their patients. In this chapter, we will discuss the biology of spinal fusions and detail each major category of biological products, from autograft to ceramics, while detailing their indications and known complications.

KW - Allograft

KW - Autograft

KW - Bone formation

KW - Bone morphogenic protein

KW - Cellular concentrates

KW - Ceramics

KW - Spinal fusion

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84902400020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902400020&partnerID=8YFLogxK

U2 - 10.1016/B978-1-84569-986-4.50006-4

DO - 10.1016/B978-1-84569-986-4.50006-4

M3 - Chapter

AN - SCOPUS:84902400020

SN - 9781845699864

SP - 233

EP - 261

BT - Biomaterials for Spinal Surgery

PB - Elsevier Ltd

ER -